Stimcell Energetics (STME) Net Income towards Common Stockholders (QoQ) (2016 - 2024)
Stimcell Energetics (STME) Net Income towards Common Stockholders (QoQ) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -85.00% |
| Feb 29, 2024 | -11.56% |
| Nov 30, 2023 | 21.32% |
| Aug 31, 2023 | 3.06% |
| May 31, 2023 | 32.82% |
| Feb 28, 2023 | 17.26% |
| Nov 30, 2022 | 7.67% |
| Aug 31, 2022 | 4.84% |
| May 31, 2022 | -36.05% |
| Feb 28, 2022 | 32.10% |
| Nov 30, 2021 | 26.48% |
| Aug 31, 2021 | -27.57% |
| May 31, 2021 | -4.82% |
| Feb 28, 2021 | 5.45% |
| Nov 30, 2020 | 5.90% |
| Aug 31, 2020 | 20.10% |
| May 31, 2020 | 29.33% |
| Feb 29, 2020 | -17.41% |
| Nov 30, 2019 | -23.73% |
| Aug 31, 2019 | 79.45% |